Literature DB >> 12079872

Relationship between insulin resistance and muscle triglyceride content in nonobese and obese experimental models of insulin resistance syndrome.

Jana Divisová1, Ludmila Kazdová, Miriam Hubová, Ellen Meschisvili.   

Abstract

In nonobese hereditary hypertriglyceridemic (HTg) rats and obese HTg Koletsky SHROB/Kol rats, muscle triglyceride accumulation and its relationship to glucose homeostasis and tissue sensitivity to insulin action were examined. Soleus muscle and diaphragm triglyceride contents were markedly increased in HTg rats as compared with controls and were further increased in obese animals. On the other hand, glucose intolerance and impairment of insulin-stimulated in vitro glycogen synthesis were of a similar degree in nonobese as well as obese animals. Results indicate that insulin resistance did not increase proportionally to muscle triglyceride content.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079872

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Effects of aerobic exercise intensity on abdominal and thigh adipose tissue and skeletal muscle attenuation in overweight women with type 2 diabetes mellitus.

Authors:  Ji Yeon Jung; Kyung Ah Han; Hee Jung Ahn; Hwi Ryun Kwon; Jae Hyuk Lee; Kang Seo Park; Kyung Wan Min
Journal:  Diabetes Metab J       Date:  2012-06-14       Impact factor: 5.376

2.  Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.

Authors:  Hana Malinska; Martina Hüttl; Olena Oliyarnyk; Irena Markova; Martin Poruba; Zuzana Racova; Ludmila Kazdova; Rostislav Vecera
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

3.  The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.

Authors:  Martina Hüttl; Irena Markova; Denisa Miklankova; Iveta Zapletalova; Martin Poruba; Zuzana Racova; Rostislav Vecera; Hana Malinska
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.